RNAZ Competitors & Alternatives
Compare Transcode Therapeutics Inc with similar stocks in the same industry
Biotechnology
RNAZ
Main Stock$8.61
Tradestie Score
55
Market Cap
$8.85M
Analyst Upside
+16.1%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.43
|
$76.55M | - | 58 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.28
|
$71.69M | - | 52 | Compare |
|
ABVC
ABVC BioPharma, Inc. Common Stock
|
$1.80
|
$70.39M | - | 60 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.34
|
$67.94M | - | 56 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$2.10
|
$12.21M | 16.4 | 52 | Compare |
|
SPRC
SciSparc Ltd. Ordinary Shares
|
$4.78
|
$9.78M | 0.0 | 52 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.28
|
$7.21M | - | 54 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$1.34
|
$3.50M | - | 49 | Compare |
More RNAZ Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry